PANASONIC-CORPORATION
16.3.2021 03:15:09 CET | Business Wire | Press release
Panasonic Corporation has begun licensing the HD-PLCTM 4*1 IP core required for the design of semiconductors with technologies and functions that comply with the IEEE 1901–2020*2 international standard. This IP core is the fourth generation of the HD-PLC series. Although conventionally HD-PLC have used power lines for transmission, this new series enables transmission through existing metal wires, such as control lines and coaxial cables as well as power lines, expanding its range of applications. This new HD-PLC technology also enables higher speeds, greater distance, and less wiring for wired communications.
By using this IP core, semiconductor and peripheral equipment manufacturers will be able to flexibly meet to a range of IoT service requirements and manufacture products that respond to these needs.
As a wide range of equipment in society becomes digitalized and connects to the IoT devices, communication technologies are becoming increasingly important. While the adoption of wireless technologies such as 5G and high-speed fiber optic internet gains pace, there are some locations in which it is difficult to access wireless communication. Here, the use of existing metal wires—in the walls and ceilings of buildings, underground facilities, and equipment—as communication mediums fulfils a vital role. This IP core is a solution that can rapidly meet to the requirements of the era of IoT, such as higher-speed networks, enhanced security, and internet protocol networks. By combining the IP core with wireless and other technologies, it can help create optimal networks in a range of environments, from living spaces to social infrastructure.
Using its experience and achievements with the HD-PLC 3 IP core, which is currently on the market, in addition to licensing of this new IP core, Panasonic will provide one-stop development support to users which will include proposals for analog front-end circuitry—key to the mounting of semiconductors. Further, as a high-speed wired communication solution, Panasonic will seek to use this technology to expand the adoption of IoT PLC, ultimately applying the technology to large-scale networks that cover living spaces, buildings, factories, smart cities, and other social infrastructure.
This IP core is first licensed to Socionext Inc. This enables the supply of higher performance semiconductors with lower energy consumption using fourth generation HD-PLC. It is expected that these will then be built-in to a range of IoT-connected devices.
Panasonic launched a dedicated website with more information about this technology. Please note that the global IEEE SA and HD-PLC Alliance*3 Webinar will be held on March 18, 2021.
Main Features
- The standard mode communication band (250 Mbps) can be doubled or quadrupled, allowing a 500 Mbps*4 communication speed in double mode or a maximum of 1 Gbps*4 in quadruple mode on coaxial cable or dedicated line.
- The standard mode communication band can be compressed on two levels (half or quarter), concentrating and extending the communication distance up to twice*5 the distance in standard mode.
- With the multi-hop function, it is possible to operate a wide area network of up to 1024 nodes.
Main Specifications
Communication
|
High-speed mode (1 Gbps, 500 Mbps) *Optional Standard mode (250 Mbps) Long-distance mode (2 x or 1.5 x the range of standard mode) |
Approved
|
IEEE 1901-2020 ITU-T G.9972 (Coexistence mechanism for different PLC systems) ITU-T G.9905 (Multi-hop) *Optional EN 50561-1:2013 (Dynamic notch and dynamic power control) |
Inquiries Regarding IP Core Licensing
IoT PLC Project Help Desk
Email: hd-plc_press@ml.jp.panasonic.com
Website: https://www.panasonic.com/global/business/hd-plc/en.html
*1: HD-PLCTM
is the name of the high-speed power line communications system proposed by Panasonic Corporation, and is a trademark or registered trademark of Panasonic Corporation in Japan and other countries. HD-PLCTM
4 is the name of the fourth-generation semiconductor IP core.
*2: Formulated by the IEEE Standards Association (a communication standards subsidiary of the Institute of Electrical and Electronics Engineers) on January 19, 2021, this is a standard for technologies with higher speeds and longer distances than those outlined in IEEE 1901-2010.
IEEE 1901-2020 - IEEE Standard for Broadband over Power Line Networks: Medium Access Control and Physical Layer Specifications: https://standards.ieee.org/standard/1901-2020.html
*3: An alliance formed on September 25, 2007, to support, promote and implement the HD-PLC system for High-Speed Power Line Communications and to ensure mutual compatibility.
Website: https://hd-plc.org/
*4: 500 Mbps and 1 Gbps are theoretical speeds at the physical layer.
*5: Maximum distance may change depending on communication environment.
About Panasonic
Panasonic Corporation is a worldwide leader in the development of diverse electronics technologies and solutions for customers in the consumer electronics, housing, automotive, and B2B businesses. The company, which celebrated its 100th anniversary in 2018, has expanded globally and now operates 528 subsidiaries and 72 associated companies worldwide, recording consolidated net sales of 7.49 trillion yen for the year ended March 31, 2020. Committed to pursuing new value through innovation across divisional lines, the company uses its technologies to create a better life and a better world for its customers. To learn more about Panasonic: https://www.panasonic.com/global
.
Source: https://news.panasonic.com/global/press/data/2021/03/en210316-2/en210316-2.html
Related Links
IEEE SA and HD-PLC Alliance Webinar March 2021: Home Networking, Industrial and Building Automation through HD-PLC (High Speed Powerline Communication)
https://standards.ieee.org/events/index.html
[Press Release] Panasonic's Next-generation HD-PLC®
, BPL Communication Technology Adopted as IEEE 1901a Standard
https://news.panasonic.com/global/press/data/2019/03/en190325-4/en190325-4.html
Socionext Inc. related press release
https://www.socionext.com/en/pr/sn_pr20210309_01e.pdf
HD-PLC Alliance
https://hd-plc.org/
View source version on businesswire.com: https://www.businesswire.com/news/home/20210315005858/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
